We are live on ! Find out more
TMCI icon

Treace Medical Concepts

115 hedge funds and large institutions have $87.8M invested in Treace Medical Concepts in 2025 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 119115 (-4)

5.29% less ownership

Funds ownership: 61.46%56.17% (-5.3%)

11% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 35

14% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 35

66% less capital invested

Capital invested by funds: $260M → $87.8M (-$172M)

88% less call options, than puts

Call options by funds: $60K | Put options by funds: $484K

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
1.4%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
31
Increased
30
Reduced
35
Closed
35
Calls
$60K
Puts
$484K
Net Calls
-$424K
Net Calls Change
-$448K
Name Holding Trade Value Shares
Change
Change in
Stake
MCM
26
Moore Capital Management
New York
$544K +$324K +74,503 +50%
Citadel Advisors
27
Citadel Advisors
Florida
$519K +$920K +211,906 New
AWMNY
28
Arcadia Wealth Management (New York)
New York
$514K
Morgan Stanley
29
Morgan Stanley
New York
$511K -$2.4M -551,586 -73%
PHP
30
Parkman Healthcare Partners
Connecticut
$489K -$2.82M -648,282 -76%
Goldman Sachs
31
Goldman Sachs
New York
$463K -$112K -25,812 -12%
Jane Street
32
Jane Street
New York
$434K +$571K +131,478 +289%
Point72 Asset Management
33
Point72 Asset Management
Connecticut
$416K +$737K +169,792 New
Stifel Financial
34
Stifel Financial
Missouri
$411K -$154K -35,431 -17%
JF
35
Jump Financial
Illinois
$380K +$673K +154,946 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$296K -$8.39K -1,932 -2%
N
37
Nuveen
North Carolina
$253K
Fidelity Investments
38
Fidelity Investments
Massachusetts
$251K +$89.7K +20,663 +25%
PCMI
39
Paradigm Capital Management Inc
New York
$245K -$651K -150,000 -60%
Barclays
40
Barclays
United Kingdom
$215K +$26.4K +6,077 +7%
JG
41
Jain Global
New York
$184K +$327K +75,206 New
XT
42
XTX Topco
Cayman Islands
$180K +$319K +73,442 New
AC
43
Aristides Capital
Kentucky
$173K +$306K +70,500 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$158K
JP Morgan Chase
45
JP Morgan Chase
New York
$156K -$6.73M -1,550,016 -96%
SSA
46
Schonfeld Strategic Advisors
New York
$154K -$1.62K -373 -0.6%
HF
47
HRT Financial
New York
$149K +$266K +61,210 New
QC
48
Quadrature Capital
United Kingdom
$149K +$263K +60,644 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$147K -$85.2K -19,614 -25%
CIAM
50
Caitong International Asset Management
Hong Kong
$140K +$248K +57,185 New

TMCI Hedge Fund Activity: Q4 2025 in Review

115 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q4 2025, worth a combined $87.8M — down 66% from $260M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of TMCI and 31 opened new positions — a net loss of 4 holders — while 35 trimmed existing stakes and 30 added.

The largest buyer was Bank of America, adding an estimated $9.68M. The largest seller was William Blair Investment Management, cutting an estimated $10.8M.

  • 115 institutional investors held Treace Medical Concepts (TMCI) as of Q4 2025, down from 119 in Q3 2025.
  • Funds reported $87.8M of Treace Medical Concepts stock for Q4 2025, down 66% quarter-over-quarter.
  • 31 funds opened new Treace Medical Concepts positions in Q4 2025 and 35 closed out, a net change of -4 holders.
  • The largest Treace Medical Concepts buyer in Q4 2025 was Bank of America, an estimated $9.68M added.
  • The largest Treace Medical Concepts seller in Q4 2025 was William Blair Investment Management, an estimated $10.8M sold.

Based on aggregated 13F filings for Q4 2025.